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ABSTRACT
We report the case of a 28-year-old man who presented with recurring episodes of high fever, pleural and pericardial effusions and 
bilateral hydrocele. He was diagnosed with  familial Mediterranean fever (FMF) and responded well to colchicine therapy. Genetic testing 
showed variants of the MEFV gene (p.Pro369Ser and p.Glu148Gln) previously independently described as having a more benign course of 
the disease. Their association is very rarely reported. Our patient and our review of the literature suggest that these genetic variants are 
associated with indolent courses but might also trigger the classic symptoms seen in severe FMF, probably in a compound heterozygous 
fashion. The combination of these variants should be taken into consideration in the diagnosis and management of patients. 
LEARNING POINTS
• Familial Mediterranean fever is characterized by recurring episodes of fever with serositis, arthritis or abdominal pain.
•	 Many	mutations	of	the	MEFV	gene	are	responsible	for	the	syndrome,	but	some	variants	are	still	of	uncertain	clinical	significance.
• The p.Pro369Ser and p.Glu148Gln variants are rarely described together and can be pathogenic.
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CASE DESCRIPTION
We report the case of a 28-year-old man who presented with recurring episodes of unexplained fever (40°C). He complained of continuous 
pain in the right upper abdominal quadrant, not related to eating or drinking. He denied chest pain or cough and did not have vomiting or 
nausea. His intestinal transit was regular, and as were his stools and urine colour. He did not have any urinary symptoms but had noticed 
painful testicular oedema which resolved after he applied ice to it. Physical examination showed mild tenderness in the right upper quadrant 
without jaundice. 
The patient was originally from Tunisia and had just returned from a recent visit there, where he had experienced an episode of fever and 
had	been	treated	with	levofloxacin	for	prostatitis.	He	was	an	active	smoker,	was	not	taking	any	other	medication	and	was	in	good	health	
before his trip.
He had been treated a year earlier in another city for pleural and pericardial effusions, thought to be of viral origin. Blood tests performed 
at the time showed a high C-reactive protein (CRP, 258 mg/l) with normal white blood cells at 7,110/mm³ with a slight neutrophil increase 
of 6,260/mm³ and lymphocytes down to 580/mm³. Haemoglobin was 12 g/dl and there was mild thrombocytopenia: platelets were 92,000/
mm³. Renal function and hepatic tests were within the normal range. Testing for CMV, EBV, hepatitis A, B and C, and HIV came back 
negative. Thoraco-abdominal computed tomography (CT) revealed small bilateral pleural as well as pericardial effusions up to 12 mm in 
European Journal
of Case Reports in
Internal Medicine
DOI: 10.12890/2019_001216 European Journal of Case Reports in Internal Medicine © EFIM 2019
size. Hepatomegaly and splenomegaly were seen on imaging along with ascites. His echocardiography results were normal except for mild 
pulmonary hypertension. Scrotum ultrasound showed bilateral hydrocele without signs of epididymitis. Blood cultures and pleural effusion 
culture came back negative. His CRP decreased under colchicine, without any antibiotic treatment, as did all effusions. He had stopped 
taking colchicine during his journey in Tunisia because he ran out of medicine.
Given his country of origin and the recurring fever and symptoms without any cardiac or infectious causes found, familial Mediterranean 
fever (FMF) was suspected and the patient was put back on colchicine which ultimately resolved all his symptoms.
The patient presented 2 months later to our emergency department with another episode of fever, headaches and testicular oedema. He 
admitted stopping his colchicine treatment again.
As all symptoms including fever returned each time the patient stopped his colchicine treatment, and as he mentioned his sister had a similar 
medical	history	with	remission	during	pregnancy,	we	decided	to	pursue	genetic	testing	to	confirm	the	suspicion	of	FMF.	Unfortunately,	our	
patient’s sibling refused to be tested for the mutations. However, genetic testing of our patient did reveal two variants of the MEFV gene: 
p.Pro369Ser and p.Glu148Gln. These two variants are rarely seen in the same person, and patients with these genetic variants presenting 
with severe FMF symptoms are seldom described in the literature.
DISCUSSION
FMF	is	a	periodic	fever	syndrome	defined	by	recurring	episodes	of	fever	and	serositis,	usually	self-limiting.	It	especially	affects	people	with	
ancestors from the Mediterranean basin but can also be encountered in Asian and Ashkenazi Jews. The disease is a hereditary autosomal 
dominant	syndrome	classified	as	an	autoinflammatory	disorder,	with	marked	elevations	of	pro-inflammatory	markers	such	as	CRP	during	
both attacks and remission. Clinical manifestations can last a few days and usually resolve spontaneously; they include high fever and diffuse 
pain in the abdomen or joints. Fever is usually present during crises. Serositis such pleural and pericardial effusions and hydroceles is often 
present. 
Since 1997, we have known that mutations in the MEFV gene, located on chromosome 16, are associated with this disease. This gene 
encodes	the	protein	pyrin	(marenostrin),	which	takes	part	in	the	inflammasome.	More	than	310	mutations	have	been	described	to	date.	
Many	gene	variants	have	been	linked	to	a	pathological	state,	although	five	are	still	of	undetermined	significance	(E148Q,	K695R,	P369S,	
F479L and I591T) [1]. 
p.Glu148Gln	(PQ148)	is	one	of	the	most	common	variants	in	FMF.	Cases	of	severe	FMF	have	been	described	in	patients	homozygous	for	
PQ148.	It	is	usually	pathogenic	when	associated	with	other	variants,	such	as	V726A.	p.Pro369Ser	(P369S)	is	another	variant	but	only	one	
case	has	been	described	as	pathogenic.	Association	of	P369S	with	other	variants	such	as	R408Q	showed	variable	phenotypes,	although	
some patients had a typical FMF presentation[2, 3].
In a hereditary autosomal dominant disease like FMF, the association of different genetic variants could cause a pathogenic state via 
compound heterozygosity. Indeed, both parents could be healthy carriers of a single variant that could become pathological in their offspring 
if associated with the other variant.
To the best of our knowledge, only three other reported cases associating both p.Pro369Ser and p.Glu148Gln have been described in the 
literature (Table 1).	The	first	patient	reported	by	Battal	et	al.	presented	only	with	abdominal	pain[3]. Another patient presented with fever, 
arthralgia and abdominal pain and had multiple mutations (p.Glu148Gln, p.Pro369Ser and p.Arg408Gln) in the MEFV gene[4]. The last case 
we	found	was	described	in	2018	and	did	not	show	any	pathogenicity	[5].	Our	patient	first	presented	with	abdominal	pain	but	developed	
serositis accompanied by fever.  
Testing	our	patient’s	parents	and	sibling	would	have	been	an	elegant	way	to	confirm	the	role	of	these	two	mutations	in	the	pathological	state,	
but they refused permission. The fact that attacks were occurring after treatment with colchicine had been stopped and improved when 
colchicine	was	started	again	was	proof	ex	juvantibus	that	confirmed	our	clinical	impression	and	genetic	tests.
CONCLUSION
It	is	crucial	to	report	symptoms	caused	by	variants	of	unknown	significance	in	order	to	achieve	better	understanding	of	clinical	presentations	
and the best way to manage them. Although rarely reported, the heterozygous state of p.Pro369Ser and p.Glu148Gln, when associated, 
might cause typical FMF symptoms.
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Table 1. Cases harbouring both p.Pro369Ser and p.Glu148Gln and their clinical characteristics
Case reports Clinical presentation Mutation Age
 Balkan J Med Genet 2016;19:23–28. Abdominal pain p.Pro369Ser/p.Glu148Gln NA
 J Korean Med Sci 2013;28:328–330 Fever, arthralgia and abdominal 
pain
p.Glu148Gln, p.Pro369Ser, and 
p.Arg408Gln
22 years old
Gene 2018;641:279–286 No pathogenicity p.Pro369Ser/p.Glu148Gln NA
Our case Fever, abdominal pain, hydrocele, 
pleural and pericardial 
effusions
p.Pro369Ser/p.Glu148Gln 28 years old
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